Hikma ends Jordanian corporate drought
Hikma Pharmaceuticals priced the first international Jordanian corporate bond in over a decade on Wednesday, finding decent demand despite not naturally fitting any one investor base.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: